Margus Annuk, Mihkel Zilmer, Bengt Fellström

Slides:



Advertisements
Similar presentations
Figure Legend: From: Immune Modulation by Volatile Anesthetics
Advertisements

From: Nitric Oxide: A Physiologic Messenger
Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting  Amr F. Barakat, MD, Marwan Saad, MD, PhD, Ahmed Abuzaid, MD, Amgad.
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model  Eric S. Weiss, MD,
Volume 151, Issue 2, Pages (February 2017)
Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1α  Alan Dardik,
Dylan Burger, Adeera Levin  Kidney International 
Volume 79, Issue 9, Pages (May 2011)
Physiology of the endothelium
Management of advanced renal cancer
Vascular endothelial dysfunction in cirrhosis
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Volume 151, Issue 2, Pages (February 2017)
Postmortem and ex vivo carbon monoxide ventilation reduces injury in rat lungs transplanted from non–heart-beating donors  Boming Dong, MD, PhD, Paul.
Innate immunity as a driving force in renal disease
Divya Gupta et al. JCHF 2013;1:
Evaluation of the microcirculation in vascular disease
Volume 56, Pages S202-S205 (July 1999)
Volume 85, Issue 3, Pages (March 2014)
Overcoming barriers that inhibit proper treatment of anemia
Yasuko Iwakiri, Vijay Shah, Don C. Rockey  Journal of Hepatology 
George A. Kaysen, Burl R. Don
Ian H. de Boer, Rajnish Mehrotra  Kidney International 
The sources of oxidative stress in the vessel wall
Volume 81, Issue 12, Pages (June 2012)
Reducing lipids for CV protection in CKD patients—current evidence
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Thomas Quaschning, Jan Galle, Christoph Wanner
Stefan Frank, Heiko Kämpfer, Christian Wetzler, Josef Pfeilschifter 
Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD 
Bisphosphonate safety and efficacy in chronic kidney disease
Volume 70, Issue 10, Pages (November 2006)
The molecular mechanisms of hemodialysis vascular access failure
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
The promise of biomarkers for personalized renal cancer care
Volume 67, Pages S51-S58 (June 2005)
Endothelial dysfunction and inflammation: What is the link?
Volume 57, Issue 3, Pages (March 2000)
Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and.
Volume 72, Issue 2, Pages (July 2007)
Mary P. Kotlarczyk, PhD, Marie Billaud, PhD, Benjamin R
Nitric oxide in acute renal failure: NOS versus NOS
AGEs in foods: Do they play a role in uremia?
Thomas Mueller, Benjamin Dieplinger  Kidney International 
Volume 87, Issue 1, Pages (January 2015)
Volume 81, Issue 8, Pages (April 2012)
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease  Shen Xiao, Laszlo Wagner, Rebecca J. Schmidt,
Figure 2 Protective functions of HDL
Volume 81, Issue 8, Pages (April 2012)
Courtney Premer, PhD, Anthony J. Kanelidis, MD, Joshua M
Homocysteine, renal function, and risk of cardiovascular disease
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Constantijn Franssen et al. JCHF 2016;4:
Volume 56, Pages S28-S30 (July 1999)
Charles A. Herzog  Kidney International 
Do Oxidized Lipoproteins Cause Atherosclerotic Cardiovascular Diseases?  Benoit J. Arsenault, PhD, Raphaëlle Bourgeois, MSc, Patrick Mathieu, MD, MSc,
Mechanism of action for pulmonary arterial hypertension medications.
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
Volume 75, Issue 6, Pages (March 2009)
William G. Couser, Jeffrey W. Pippin, Stuart J. Shankland 
Biology of endothelin receptors in the collecting duct
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?  Ellen G. Neven, Marc E. De Broe, Patrick.
Impaired Lung Function and Risk for Stroke
Development and differentiation of endothelium
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Margus Annuk, Mihkel Zilmer, Bengt Fellström Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: Impact on cardiovascular disease  Margus Annuk, Mihkel Zilmer, Bengt Fellström  Kidney International  Volume 63, Pages S50-S53 (May 2003) DOI: 10.1046/j.1523-1755.63.s84.2.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Reactive oxygen species (ROS) impair vascular function. Vascular function is impaired by injury to endothelial and vascular smooth muscle cell membranes; reaction with nitric oxide (NO) and inactivation; oxidization of tetrahydrobiopterin (BH4) as cofactor of nitric oxide synthase (NOS); peroxidization of low-density lipoprotein (LDL) to oxidized LDL (oxLDL); stimulation of synthesis of asymmetric dimethylarginine (ADMA)-yielding NOS inhibition; inhibition of guanylyl cyclase, which leads to decreased production of cyclic guanosine monophosphate (cGMP), activation of platelet aggregation and adhesion; and oxLDL, formed under influence of ROS, which may cause upregulation of receptors of adhesion molecules on endothelial cells, platelet derived growth factor (PDGF) receptors on smooth muscle cells (SMC), PDGF synthesis by SMC, and HLA expression on monocytes. Abbreviations are: ECM, extracellular matrix; IL-1, interleukin 1; GTP, guanosine triphosphate; mRNA, messenger RNA. Kidney International 2003 63, S50-S53DOI: (10.1046/j.1523-1755.63.s84.2.x) Copyright © 2003 International Society of Nephrology Terms and Conditions